Jaguar Health issues equity to retire debt and acquire Napo Therapeutics minority stake

Jaguar Health, Inc.

Issued 557,377 shares to Lincoln Alternative to retire 6% convertible note with $175,016.36 balance on Sept 11, 2026.
Exchanged 304,473 total shares to Streeterville for 9.2 Series Q preferred shares across 3 agreements (Jul 7, Sep 11, Sep 14, 2026).
Closed Sep 15 purchase of a shareholder's Napo Therapeutics S.p.A. stake for 535,000 shares plus pre-funded warrant for 2,077,255 shares.
All issuances under Section 3(a)(9) and 4(a)(2) exemptions; shares free of restrictive legends with Rule 144 holding-period tacking.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.